|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Cortavance
|
|
Active substances:
|
|
|
ATC code:
|
QD07AC16
|
|
Dosage form:
|
cutaneous spray, solution
|
|
Strength:
|
0,584mg 1ml
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.
For alleviation of clinical signs associated with atopic dermatitis in dogs.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Virbac
|
|
Marketing authorization number:
|
EU/2/06/069
|
|
Marketing authorization issued on:
|
January 9, 2007
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1278233
|
Cortavance
|
cutaneous spray, solution
|
0,584mg 1ml 76ml 1TK
|
Prescription
|
|
|
14.03.2023
|
|
|
|
1663332
|
Cortavance
|
cutaneous spray, solution
|
0,584mg 1ml 31ml 1TK
|
Prescription
|
|
|
08.06.2023
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere